.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Johnson and Johnson
Colorcon
US Department of Justice
Cipla
Daiichi Sankyo
Chubb
UBS

Generated: September 24, 2017

DrugPatentWatch Database Preview

ATROPEN Drug Profile

« Back to Dashboard

What is the patent landscape for Atropen, and what generic Atropen alternatives are available?

Atropen is a drug marketed by Meridian Medcl Techn and is included in one NDA.

The generic ingredient in ATROPEN is atropine. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine profile page.

Summary for Tradename: ATROPEN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list28
Clinical Trials: see list2
Patent Applications: see list5,778
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATROPEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl Techn
ATROPEN
atropine
INJECTABLE;INJECTION017106-004Sep 17, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Meridian Medcl Techn
ATROPEN
atropine
INJECTABLE;INJECTION017106-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Meridian Medcl Techn
ATROPEN
atropine
INJECTABLE;INJECTION017106-003Jun 19, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Meridian Medcl Techn
ATROPEN
atropine
INJECTABLE;INJECTION017106-002Jun 19, 2003RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Dow
US Department of Justice
Harvard Business School
Chinese Patent Office
Boehringer Ingelheim
Julphar
Baxter
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot